Escalating Prescription Drug Costs: Ten New Breakthrough Drugs Are Just the Tip of the Iceberg
posted by AHIP
on April 2, 2015
According to a new report by Avalere, over the next decade, ten breakthrough drugs are estimated to cost three government programs nearly $50 billion. Notably, the analysis adds that “total U.S. spending may exceed these estimates” when accounting for spending by other government agencies, costs to private sector payers, patient out-of-pocket costs, and the significant spending increases associated with off-label use. This price tag represents a ‘small subset’ of the total cost of the pharmaceutical pipeline for patients and the federal government.